Business Context and Reporting Period
This Form 8-K is filed by WellPoint, Inc. (now Elevance Health, Inc.) on March 21, 2005, reporting events occurring on March 15, 2005. The filing details the authorization of 2004 long-term incentive awards and the establishment of 2005 executive compensation packages.
Key Financial Metrics and Compensation Data
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics. It focuses exclusively on executive compensation figures:
- 2004 Long-Term Incentive Cash Awards: Total cash payments to Named Executive Officers (NEOs) for the 2004 performance period were authorized, with CEO Larry C. Glasscock receiving $2,023,620.
- 2005 Executive Compensation Structure:
- CEO Salary: Larry C. Glasscock's 2005 salary is set at $1,250,000.
- Equity Grants: 2005 stock option grants range from 50,000 to 200,000 shares; restricted stock awards range from 6,250 to 25,000 shares.
- Bonus Targets: Annual bonus targets range from 80% to 125% of base salary, contingent on performance measures including diluted earnings per share and membership growth.
Material Changes and Personnel Updates
Significant personnel changes impact the 2005 executive roster:
- Retirements: David R. Frick announced retirement effective July 1, 2005. Michael L. Smith retired effective January 31, 2005.
- NEO Status Changes: Due to the retirements, David C. Colby and David S. Helwig are anticipated to become Named Executive Officers for 2005 based on their salary and bonus targets.
- Compensation Adjustments: Mr. Frick and Mr. Smith received no 2005 salary, stock options, or restricted stock awards in this filing.
Guidance, Outlook, and Management Commentary
Officers of WellPoint expect to meet with securities analysts and investors between March 21, 2005, and March 31, 2005. During these meetings, management intends to confirm the company's ability to meet earnings expectations previously communicated in a press release and conference call on February 7, 2005. No new quantitative guidance is provided in this document.
Investor Verification Checklist
- Verify the specific performance metrics (diluted EPS, synergy goals, membership growth) used to calculate the 2004 incentive awards.
- Confirm the actual vesting dates and exercise prices for the 2005 stock options and restricted stock, which are tied to the April 4, 2005 market close.
- Review the February 7, 2005 press release (Exhibit 99 to a prior filing) to understand the earnings expectations management plans to reaffirm.
- Monitor the transition of NEO status to David C. Colby and David S. Helwig in subsequent filings.